CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hill, R. J.
Right arrow Articles by Gishizky, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hill, R. J.
Right arrow Articles by Gishizky, M. L.

Cell Growth & Differentiation, Vol 7, Issue 9 1125-1134, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein

RJ Hill, S Zozulya, YL Lu, PW Hollenbach, B Joyce-Shaikh, J Bogenberger and ML Gishizky
Department of Hematology, SUGEN, Inc., Redwood City, California 94063, USA. Ronald@SUGEN.SF.CA.US

c-Mpl, a member of the cytokine receptor superfamily, induces both proliferative and differentiation responses when stimulated with its ligand thrombopoietin (TPO). To examine signal transduction pathways associated with differentiation versus proliferation, 32D clone 3 cells, a murine interleukin 3-(IL-3)-dependent cell line capable of granulocytic differentiation, were engineered to express human c-Mpl (designated 32DM.2). Human TPO-containing medium was produced by transient transfection of 293 cells. Treatment of 32DM.2 cells with human TPO induced cellular aggregates within 12 h of exposure to ligand. 32DM.2 cells maintained in the presence of TPO did not change in cell number over a 72-h period and acquired characteristics of granulocytic differentiation as evidenced by metamyelocytic cellular morphology. The differentiation effect of TPO was observed in the absence and presence of the mitogen IL-3. Evaluation of protein tyrosine phosphorylation following exposure to ligand revealed that TPO stimulation induced an elevated level of tyrosine phosphorylation of the adaptor protein Shc when compared with IL-3. However, treatment of 32DM.2 cells with TPO did not result in the phosphorylation of mitogen-activated protein kinase (MAPK). To evaluate the potential role of Shc in c-Mpl differentiation, we transfected 32DM.2 cells with a mutant Shc gene that lacked the region coding for the phosphotyrosine interaction domain (delta PI-Shc). Expression of the delta PI-Shc protein in 32DM.2 cells blocked the TPO differentiation response with no effect on IL-3-stimulated proliferation. These studies demonstrate that c-Mpl-induced differentiation results from the activation of signal transduction pathways that are dominant to the IL-3 proliferative response and independent of the Ras/MAPK signal transduction pathway. The ability of the delta PI-Shc protein to block TPO-induced differentiation implicates Shc as a mediator of signal transduction pathways leading to differentiation, which is distinct from its role as a mediator in activating the Ras/MAPK pathway.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
J. R. Sevinsky, A. M. Whalen, and N. G. Ahn
Extracellular Signal-Regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene through MafB/Kreisler
Mol. Cell. Biol., May 15, 2004; 24(10): 4534 - 4545.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-D. Filippi, F. Porteu, F. L. Pesteur, V. Schiavon, G. A. Millot, W. Vainchenker, F. J. de Sauvage, A. Dubart Kupperschmitt, and F. Sainteny
Requirement for mitogen-activated protein kinase activation in the response of embryonic stem cell-derived hematopoietic cells to thrombopoietin in vitro
Blood, February 15, 2002; 99(4): 1174 - 1182.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
X. F. Csar, N. J. Wilson, K.-A. McMahon, D. C. Marks, T. L. Beecroft, A. C. Ward, G. A. Whitty, V. Kanangasundarum, and J. A. Hamilton
Proteomic Analysis of Macrophage Differentiation: p46/52Shc TYROSINE PHOSPHORYLATION IS REQUIRED FOR CSF-1-MEDIATED MACROPHAGE DIFFERENTIATION
J. Biol. Chem., July 13, 2001; 276(28): 26211 - 26217.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. A. Blake, M. A. Broome, X. Liu, J. Wu, M. Gishizky, L. Sun, and S. A. Courtneidge
SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
Mol. Cell. Biol., December 1, 2000; 20(23): 9018 - 9027.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Hodohara, N. Fujii, N. Yamamoto, and K. Kaushansky
Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK)
Blood, February 1, 2000; 95(3): 769 - 775.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S.-M. Luoh, E. Stefanich, G. Solar, H. Steinmetz, T. Lipari, T. I. Pestina, C. W. Jackson, and F. J. de Sauvage
Role of the Distal Half of the c-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin In Vivo
Mol. Cell. Biol., January 15, 2000; 20(2): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. P. Miller, Z. Y. Liu, C. T. Noguchi, and D. M. Wojchowski
A Minimal Cytoplasmic Subdomain of the Erythropoietin Receptor Mediates Erythroid and Megakaryocytic Cell Development
Blood, November 15, 1999; 94(10): 3381 - 3387.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. G. Drachman, K. M. Millett, and K. Kaushansky
Thrombopoietin Signal Transduction Requires Functional JAK2, Not TYK2
J. Biol. Chem., May 7, 1999; 274(19): 13480 - 13484.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. P. O'Bryan, Q. T. Lambert, and C. J. Der
The Src Homology 2 and Phosphotyrosine Binding Domains of the ShcC Adaptor Protein Function as Inhibitors of Mitogenic Signaling by the Epidermal Growth Factor Receptor
J. Biol. Chem., August 7, 1998; 273(32): 20431 - 20437.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
T. E. Smithgall
Signal Transduction Pathways Regulating Hematopoietic Differentiation
Pharmacol. Rev., March 1, 1998; 50(1): 1 - 20.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. G. Drachman and K. Kaushansky
Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain
PNAS, March 18, 1997; 94(6): 2350 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
X. F. Csar, N. J. Wilson, K.-A. McMahon, D. C. Marks, T. L. Beecroft, A. C. Ward, G. A. Whitty, V. Kanangasundarum, and J. A. Hamilton
Proteomic Analysis of Macrophage Differentiation: p46/52Shc TYROSINE PHOSPHORYLATION IS REQUIRED FOR CSF-1-MEDIATED MACROPHAGE DIFFERENTIATION
J. Biol. Chem., July 13, 2001; 276(28): 26211 - 26217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.